Everything you need to know about the valuation of Moderna

Actions of Modern (NASDAQ: MRNA) This year it has more than tripled as biotechnology has rapidly boosted its coronavirus vaccine, mRNA-1273, through the clinical trial process. MRNA data by YCharts. Whether Moderna’s shares can go even higher from here depends on multiple factors, some of which are beyond the company’s …

Read More »